Home
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Talent Development
Join Us
CH
News&Information
News & Information
Home
>
News & Information
>
Company News
Company News
Media Reports
media reports
Media Reports
2020-08-25
动脉网:裕策生物完成近3亿元人民币C轮融资,打造肿瘤精准免疫诊疗一体化解决方案
MORE
2020-08-10
深圳新闻网:盐田区营商环境持续优化 科技企业发展驶入快车道
MORE
2020-08-09
凤凰网:裕策生物五周年庆典 嘉宾云集共同见证
MORE
2020-01-20
动脉网:“基因+免疫”双轮驱动,裕策生物用新生抗原预测原理让肿瘤免疫更精准
MORE
2020-01-15
动脉网:逐鹿肿瘤精准免疫诊断,我们盘点热门生物标志物后发现了这样的趋势
MORE
2020-01-08
动脉网:裕策生物高志博:做下一代免疫治疗的重要合作伙伴,肿瘤新生抗原检测引领行业风潮
MORE
First
Previous
1
2
3
4
Next
Last
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Career Development
Join Us
Copyright©2021
Shenzhen yucebio Technology Co., Ltd. all rights reserved
Yueicp no.16128839
Technical support: muxing planning
Top